RELAPSED AML

Clinical trials for RELAPSED AML explained in plain language.

Never miss a new study

Get alerted when new RELAPSED AML trials appear

Sign up with your email to follow new studies for RELAPSED AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Experimental combo targets tough leukemia in early trial

Disease control Ongoing

This early-phase study tests whether combining CART123 cells (a type of immune cell therapy) with the drug ruxolitinib is safe and feasible for adults with acute myeloid leukemia (AML) that has returned or not responded to standard treatments. Twelve participants will receive a s…

Matched conditions: RELAPSED AML

Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control

Last updated May 01, 2026 15:57 UTC

RELAPSED AML

Get alerted when new RELAPSED AML trials appear

Experimental combo targets tough leukemia in early trial